Monel B, Lamothe P, Meyo J, McLean A, Quinones-Alvarado R, Laporte M
bioRxiv. 2025; .
PMID: 39896504
PMC: 11785116.
DOI: 10.1101/2025.01.20.633914.
Song S, Wang C, Chen Y, Zhou X, Han Y, Zhang H
Cancer Immunol Immunother. 2025; 74(3):92.
PMID: 39891668
PMC: 11787113.
DOI: 10.1007/s00262-024-03936-7.
Lin N, Yin W, Miller H, Byazrova M, Herrada A, Benlagha K
Front Immunol. 2023; 14:1169601.
PMID: 37275865
PMC: 10235474.
DOI: 10.3389/fimmu.2023.1169601.
Rietdijk S, Keszei M, Castro W, Terhorst C, Abadia-Molina A
Int J Mol Sci. 2023; 24(5).
PMID: 36902453
PMC: 10003074.
DOI: 10.3390/ijms24055024.
Munz C
Biomolecules. 2022; 12(1).
PMID: 35053187
PMC: 8774114.
DOI: 10.3390/biom12010038.
PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8 T cells at the expense of central memory.
Cannons J, Villarino A, Kapnick S, Preite S, Shih H, Gomez-Rodriguez J
Cell Rep. 2021; 37(2):109804.
PMID: 34644563
PMC: 8582080.
DOI: 10.1016/j.celrep.2021.109804.
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control.
Quixabeira D, Zafar S, Santos J, Cervera-Carrascon V, Havunen R, Kudling T
Front Immunol. 2021; 12:674400.
PMID: 34084172
PMC: 8168464.
DOI: 10.3389/fimmu.2021.674400.
Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.
Velnati S, Centonze S, Girivetto F, Baldanzi G
Int J Mol Sci. 2021; 22(11).
PMID: 34072296
PMC: 8198409.
DOI: 10.3390/ijms22115816.
SLAM Associated Protein Signaling in T Cells: Tilting the Balance Toward Autoimmunity.
Gartshteyn Y, Askanase A, Mor A
Front Immunol. 2021; 12:654839.
PMID: 33936082
PMC: 8086963.
DOI: 10.3389/fimmu.2021.654839.
Performance Comparison of Deep Learning Autoencoders for Cancer Subtype Detection Using Multi-Omics Data.
Franco E, Rana P, Cruz A, Calderon V, Azevedo V, Ramos R
Cancers (Basel). 2021; 13(9).
PMID: 33921978
PMC: 8122584.
DOI: 10.3390/cancers13092013.
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
Radomir L, Kramer M, Perpinial M, Schottlender N, Rabani S, David K
Nat Commun. 2021; 12(1):1893.
PMID: 33767202
PMC: 7994628.
DOI: 10.1038/s41467-021-22230-z.
Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.
Gilfillan C, Hebeisen M, Rufer N, Speiser D
Eur J Immunol. 2021; 51(6):1348-1360.
PMID: 33704770
PMC: 8252569.
DOI: 10.1002/eji.202049016.
SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint.
Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, David I
Elife. 2020; 9.
PMID: 32122464
PMC: 7075692.
DOI: 10.7554/eLife.52539.
Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells.
Dienz O, DeVault V, Musial S, Mistri S, Mei L, Baraev A
J Immunol. 2020; 204(6):1521-1534.
PMID: 32024701
PMC: 7065973.
DOI: 10.4049/jimmunol.1901082.
The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E, Mattner J
Front Immunol. 2019; 10:1449.
PMID: 31293596
PMC: 6603179.
DOI: 10.3389/fimmu.2019.01449.
SLAMF6 in health and disease: Implications for therapeutic targeting.
Yigit B, Wang N, Herzog R, Terhorst C
Clin Immunol. 2018; 204:3-13.
PMID: 30366106
PMC: 8969216.
DOI: 10.1016/j.clim.2018.10.013.
The novel immunoglobulin super family receptor SLAMF9 identified in TAM of murine and human melanoma influences pro-inflammatory cytokine secretion and migration.
Dollt C, Michel J, Kloss L, Melchers S, Schledzewski K, Becker K
Cell Death Dis. 2018; 9(10):939.
PMID: 30232321
PMC: 6145869.
DOI: 10.1038/s41419-018-1011-1.
Insights Into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology.
Qin L, Waseem T, Sahoo A, Bieerkehazhi S, Zhou H, Galkina E
Front Immunol. 2018; 9:1884.
PMID: 30158933
PMC: 6104131.
DOI: 10.3389/fimmu.2018.01884.
Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8 T Cell Survival, Differentiation, and Function.
Cannons J, Preite S, Kapnick S, Uzel G, Schwartzberg P
Front Immunol. 2018; 9:1758.
PMID: 30116245
PMC: 6082933.
DOI: 10.3389/fimmu.2018.01758.
Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
Latour S, Winter S
Front Immunol. 2018; 9:1103.
PMID: 29942301
PMC: 6004768.
DOI: 10.3389/fimmu.2018.01103.